Effective January 2, 2024, Harrow, Inc. appointed John P. Saharek as the President and Chief Executive Officer of the Company?s ImprimisRx division, in addition to his current role as Chief Commercial Officer of the Company. Mr. Saharek will continue to report to Mark L. Baum, Chief Executive Officer and Chairman of the Company.